CRC Research Update

🔬 Under 50 Spotlight

Research relevant to early-onset and younger CRC patients

🧬 Biomarker Spotlight

Research by genetic subtype. KRAS, BRAF, MSI-H, HER2, and more

Today's research spans early-life carcinogen exposures, risk stratification tools for hereditary syndromes, and new treatment approvals for RAS-driven tumors.